$2.52 Billion is the total value of Weiss Multi-Strategy Advisers LLC's 535 reported holdings in Q1 2017. The portfolio turnover from Q4 2016 to Q1 2017 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| LEN | LENNAR CLASS -Aput | $16,714,000 | +19.2% | 326,500 | 0.0% | 0.66% | -2.5% | |
| PEGI | PATTERN ENERGY GROUP INC | $12,078,000 | +6.0% | 600,000 | 0.0% | 0.48% | -13.4% | |
| WMB | WILLIAMS COScall | $5,918,000 | -5.0% | 200,000 | 0.0% | 0.24% | -22.2% | |
| FDC | FIRST DATAput | $5,503,000 | +9.3% | 355,000 | 0.0% | 0.22% | -10.7% | |
| AERI | AERIE PHARMACEUTICALS INC | $2,993,000 | +19.8% | 66,000 | 0.0% | 0.12% | -1.7% | |
| TTWO | TAKE-TWO INTERACTIVE | $2,964,000 | +20.2% | 50,000 | 0.0% | 0.12% | -1.7% | |
| GSK | GLAXOSMITHKLINE PLC ADR | $2,403,000 | +9.5% | 57,000 | 0.0% | 0.10% | -11.2% | |
| EVA | ENVIVA PARTNERS LP | $2,108,000 | +4.9% | 75,000 | 0.0% | 0.08% | -14.3% | |
| GLPG | GALAPAGOS NV | $1,465,000 | +34.3% | 17,000 | 0.0% | 0.06% | +9.4% | |
| GNMK | GENMARK DIAGNOSTICS INC | $897,000 | +4.7% | 70,000 | 0.0% | 0.04% | -14.3% | |
| ATRC | ATRICURE INC | $718,000 | -2.2% | 37,500 | 0.0% | 0.03% | -22.2% | |
| IMMU | IMMUNOMEDICS | $712,000 | +76.2% | 110,000 | 0.0% | 0.03% | +40.0% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLC | $606,000 | +35.9% | 110,000 | 0.0% | 0.02% | +9.1% | |
| FLDM | FLUIDIGM CORP | $569,000 | -21.8% | 100,000 | 0.0% | 0.02% | -34.3% | |
| PACB | PACIFIC BIOSCIENCES OF CALIF | $553,000 | +35.9% | 107,000 | 0.0% | 0.02% | +10.0% | |
| SGMO | SANGAMO BIOSCIENCES INC | $442,000 | +70.7% | 85,000 | 0.0% | 0.02% | +38.5% | |
| WMGI | WRIGHT MEDICAL GROUP NV | $436,000 | +35.4% | 14,000 | 0.0% | 0.02% | +6.2% | |
| IRTC | IRHYTHM TECHNOLOGIES INC | $376,000 | +25.3% | 10,000 | 0.0% | 0.02% | 0.0% | |
| AGEN | AGENUS INC | $343,000 | -8.5% | 91,000 | 0.0% | 0.01% | -22.2% | |
| ADXS | ADVAXIS INC | $327,000 | +14.3% | 40,000 | 0.0% | 0.01% | -7.1% | |
| ALDX | ALDEYRA THERAPEUTICS INC | $325,000 | -6.6% | 65,000 | 0.0% | 0.01% | -23.5% | |
| NVS | NOVARTIS ADR | $260,000 | +2.0% | 3,500 | 0.0% | 0.01% | -16.7% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $232,000 | +38.9% | 70,000 | 0.0% | 0.01% | +12.5% | |
| PRTK | PARATEK PHARMACEUTICALS INC | $193,000 | +25.3% | 10,000 | 0.0% | 0.01% | +14.3% | |
| OBLN | OBALON THERAPEUTICS INC | $160,000 | +20.3% | 15,000 | 0.0% | 0.01% | 0.0% | |
| ALIM | ALIMERA SCIENCES INC | $119,000 | +29.3% | 85,000 | 0.0% | 0.01% | +25.0% | |
| CPRX | CATALYST PHARMACEUTICALS PAR | $133,000 | +87.3% | 68,000 | 0.0% | 0.01% | +66.7% | |
| XENE | XENON PHARMACEUTICALS INC | $126,000 | -48.1% | 31,500 | 0.0% | 0.01% | -58.3% | |
| FOLD | AMICUS THERAPEUTICS INC | $71,000 | +42.0% | 10,000 | 0.0% | 0.00% | +50.0% | |
| GERN | GERON CORP | $45,000 | +9.8% | 20,000 | 0.0% | 0.00% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DEXCOM INC | 42 | Q3 2023 | 0.4% |
| EDWARDS LIFESCIENCE CORPORAT | 42 | Q3 2023 | 0.3% |
| MERCK & CO | 42 | Q3 2023 | 0.4% |
| BIOMARIN PHARMACEUTICAL | 42 | Q3 2023 | 0.4% |
| VERTEX PHARMACEUTICA | 41 | Q3 2023 | 0.5% |
| RIGEL PHARMACEUTICALS INC | 41 | Q3 2023 | 0.1% |
| BOSTON SCIENTIFIC | 40 | Q3 2023 | 0.4% |
| PACIFIC BIOSCIENCES OF CALIF | 40 | Q3 2023 | 0.5% |
| ASTRAZENECA PLC-SPONS ADR | 39 | Q3 2023 | 0.3% |
| ABIOMED INC | 38 | Q3 2022 | 0.3% |
View Weiss Multi-Strategy Advisers LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| COMSCORE, INC. | February 14, 2023 | 9,022,812 | 9.8% |
| NETSTREIT Corp.Sold out | February 14, 2023 | 0 | 0.0% |
| RPT RealtySold out | February 14, 2022 | 0 | 0.0% |
| Tiberius Acquisition Corp | February 12, 2019 | 1,327,700 | 6.2% |
| Ashford Hospitality Prime, Inc. | February 14, 2017 | 1,183,378 | 4.6% |
| Community Bankers Trust Corp | February 12, 2014 | 500,000 | 2.3% |
| Crumbs Bake Shop, Inc.Sold out | February 12, 2013 | 0 | 0.0% |
| WESTERN LIBERTY BANCORP | February 13, 2012 | 1,165,817 | 8.1% |
| 57th Street General Acquisition Corp | February 11, 2011 | 350,000 | 5.8% |
| CENTERLINE HOLDING CO | February 11, 2011 | 2,759,200 | 0.8% |
View Weiss Multi-Strategy Advisers LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-12 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
View Weiss Multi-Strategy Advisers LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.